subject area of
- Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination Academic Article
- Andexanet alfa for the treatment of hemorrhage Academic Article
- BAY 43-9006: Early Clinical Data in Patients with Advanced Solid Malignancies Academic Article
- Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital Academic Article
- CCI-779 Wyeth. Academic Article
- Drug evaluation: E-5564. Academic Article
- Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors Academic Article
- Heterogeneity among lists of cautioned or prohibited drugs in protocols of early-phase oncology trials Academic Article
- Human type 5 adenovirus-based tuberculosis vaccine: is the respiratory route of delivery the future? Academic Article
- Idarucizumab Academic Article
- Implementation of Timeline Reforms Speeds Initiation of National Cancer Institute-Sponsored Trials Academic Article
- Improving the Quality of Abstract Reporting for Phase I Cancer Trials Academic Article
- International phase I study protocol to develop a patient-reported outcome measure for adolescents and adults receiving gender-affirming treatments (the GENDER-Q) Academic Article
- Objective Responses in Patients with Malignant Melanoma or Renal Cell Cancer in Early Clinical Studies Do Not Predict Regulatory Approval Academic Article
- Overview of phase I studies of intravenous administration of PV701, an oncolytic virus. Academic Article
- Phase I/II trials of 186Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival Academic Article
- Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of 111In-BzDTPA-pertuzumab Academic Article
- Recent advances in immunotherapy of B-CLL using ex vivo modified dendritic cells Academic Article
- Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors Academic Article
- The arotinoids: early clinical experience and discussion of future development. Academic Article
- The case for conducting first-in-human (phase 0 and phase 1) clinical trials in low and middle income countries Academic Article
- Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials Academic Article